
Sign up to save your podcasts
Or


Plus: U.S. regulators are investigating several big banks over how they respond when customers dispute transactions on the payment platform Zelle. Novo Nordisk said quarterly sales of its weight-loss drug Wegovy missed expectations. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By The Wall Street Journal4.2
652652 ratings
Plus: U.S. regulators are investigating several big banks over how they respond when customers dispute transactions on the payment platform Zelle. Novo Nordisk said quarterly sales of its weight-loss drug Wegovy missed expectations. J.R. Whalen reports.
Sign up for the WSJ's free What's News newsletter.
Learn more about your ad choices. Visit megaphone.fm/adchoices

2,847 Listeners

1,730 Listeners

4,401 Listeners

407 Listeners

437 Listeners

1,655 Listeners

1,449 Listeners

1,044 Listeners

1,314 Listeners

6,119 Listeners

1,579 Listeners

214 Listeners

1,324 Listeners

585 Listeners

151 Listeners

85 Listeners

80 Listeners

146 Listeners